Amelioration of disordered hepatic protein synthesis by the deleted form of hepatocyte growth factor in models of liver failure in rats

被引:19
|
作者
Masunaga, H
Fujise, N
Shiota, A
Yamashita, Y
Yasuda, H
Higashio, K
机构
[1] Life Science Research Institute, Snow Brand Milk Products Co. Ltd., Shimotsuga-gun, Tochigi 329-05
关键词
D O I
10.1111/j.2042-7158.1996.tb03991.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Because the liver plays an important role in protein synthesis and cholesterol metabolism and reductions in these functions are observed in almost all hepatic disorders, the effects of the deleted form of hepatocyte growth factor (dHGF) on disordered hepatic protein synthesis were studied in various liver-injured rat models using Wistar male rats. In the 70% hepatectomized rats, plasma clotting time was prolonged and the serum level of total protein and the liver protein content were decreased. The treatment of the animals with dHGF (100-500 mu g kg(-1), i.v., twice daily) ameliorated these parameters at 48 or 72 h. The administration of carbon tetrachloride or D-galactosamine to hepatectomized rats induced a marked prolongation of plasma clotting time and hypoproteinaemia. In the animals treated with dHGF (500 mu g kg(-1), i.v., twice daily) these parameters were rapidly reversed compared with those of control groups. In a hepatocellular necrosis model induced by dimethylnitrosamine, the plasma clotting time was extremely prolonged, and liver protein content, serum total protein, albumin, HDL-cholesterol (as an index of lipoprotein) and plasma lecithin-cholesterol acyltransferase activity severely reduced. In this severely injured model, dHGF (5-500 mu g kg(-1), i.v., twice daily for 28 days) dose-dependently prevented the loss of liver protein content and improved the disordered plasma coagulability and serum protein levels. These results suggest that dHGF is useful for ameliorating the disorders in hepatic functions such as protein synthesis.
引用
收藏
页码:876 / 879
页数:4
相关论文
共 50 条
  • [41] Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats
    Yasuda, H
    Imai, E
    Shiota, A
    Fujise, N
    Morinaga, T
    Higashio, K
    HEPATOLOGY, 1996, 24 (03) : 636 - 642
  • [42] IMPORTANCE OF THE LIVER IN PLASMA-CLEARANCE OF HEPATOCYTE GROWTH-FACTOR IN RATS
    LIU, KX
    KATO, Y
    NARUKAWA, M
    KIM, DC
    HANANO, M
    HIGUCHI, O
    NAKAMURA, T
    SUGIYAMA, Y
    AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (05): : G642 - G649
  • [43] APOPTOSIS IN THE LIVER AFTER DISCONTINUATION OF HEPATOCYTE GROWTH-FACTOR ADMINISTRATION IN RATS
    NAGOSHI, S
    SUDA, J
    YASUDA, H
    HIGASHIO, K
    FUJIWARA, K
    HEPATOLOGY, 1995, 22 (04) : 490 - 490
  • [44] The role of the spleen, platelets, and plasma hepatocyte growth factor activity on hepatic regeneration in rats
    Tomikawa, M
    Hashizume, M
    Higashi, H
    Ohta, M
    Sugimachi, K
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1996, 182 (01) : 12 - 16
  • [45] Endoplasmic reticulum stress restrains hepatocyte growth factor expression in hepatic stellate cells and rat acute liver failure model
    Liu, Yuting
    Pan, Xiongxiong
    Li, Shu
    Yu, Yue
    Chen, Jianliang
    Yin, Jie
    Li, Guoqiang
    CHEMICO-BIOLOGICAL INTERACTIONS, 2017, 277 : 43 - 54
  • [46] Hepatocyte transplantation prolongs survival and triggers liver regeneration in rats with fulminant hepatic failure.
    Eguchi, S
    Kamlot, A
    Hewitt, WR
    Corno, V
    Suh, K
    Arkadopoulos, N
    Lilja, MH
    Demetriou, AA
    Rozga, J
    HEPATOLOGY, 1996, 24 (04) : 723 - 723
  • [47] Hepatocyte apoptosis and hepatic expression of transforming growth factor-β1 mRNA during involution of hyperplastic rat liver induced by hepatocyte growth factor
    Nagoshi, S
    Yasuda, H
    Suda, J
    Yamanobe, F
    Ohno, A
    Higashio, K
    Fujiwara, K
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1998, 13 (08) : 786 - 793
  • [48] HEPATIC GROWTH INDUCED BY INJECTION OF THE LIVER GROWTH-FACTOR INTO NORMAL RATS
    GIL, JJD
    RUA, C
    MACHIN, C
    CERECEDA, RM
    GARCIACANERO, R
    DEFORONDA, M
    DEDIEGO, JP
    TRILLA, C
    ESCARTIN, P
    GROWTH REGULATION, 1994, 4 (03): : 113 - 122
  • [49] Hepatocyte growth factor reverses atrophy by inducing protein synthesis in mice
    Hauerslev, S.
    Vissing, J.
    Krag, T. O.
    NEUROMUSCULAR DISORDERS, 2012, 22 (9-10) : 863 - 863
  • [50] Effects of the portal infusion of a deletion variant of hepatocyte growth factor (dHGF) and activin binding protein (follistatin) on hepatic regeneration after hepatectomy in rats with liver cirrhosis.
    Ogawa, N
    Ohkohchi, N
    Satomi, S
    HEPATOLOGY, 2000, 32 (04) : 190A - 190A